Biology Reference
In-Depth Information
mice lacking the protein kinase Akt2 (PKB β).
Science
292: 1728-1731
98 Chen WS, Xu PZ, Gottlob K, Chen ML, Sokol K, Shiyanova T, Roninson I, Weng W, Suzuki R,
Tobe K et al. (2001) Growth retardation and increased apoptosis in mice with homozygous dis-
ruption of the Akt1 gene.
Genes Dev
15: 2203-2208
99 Marshall CJ (1995) Specificity of receptor tyrosine kinase signaling: transient
versus
sustained
extracellular signal-regulated kinase activation.
Cell
80: 179-185
100 Gobert S, Duprez V, Lacombe C, Gisselbrecht S, Mayeux P (1995) The signal transduction path-
way of erythropoietin involves three forms of mitogen-activated protein (MAP) kinase in UT7
erythroleukemia cells.
Eur J Biochem
234: 75-83
101 Nagata Y, Nishida E, Todokoro K (1997) Activation of JNK signaling pathway by erythropoietin,
thrombopoietin, and interleukin-3.
Blood
89:2664-2669
102 Nagata Y, Moriguchi T, Nishida E, Todokoro K (1997) Activation of p38 MAP kinase pathway
by erythropoietin and interleukin-3.
Blood
90: 929-934
103 Nagata Y, Takahashi N, Davis RJ, Todokoro K (1998) Activation of p38 MAP kinase and JNK
but not ERK is required for erythropoietin-induced erythroid differentiation.
Blood
92:
1859-1869
104 Nagata Y, Todokoro K (1999) Requirement of activation of JNK and p38 for environmental
stress-induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis.
Blood
94: 853-863
105 Miura Y, Miura O, Ihle JN, Aoki N (1994) Activation of the mitogen-activated protein kinase
pathway by the erythropoietin receptor.
J Biol Chem
269:29962-29969
106 Sakamoto H, Kitamura T, Yoshimura A (2000) Mitogen-activated protein kinase plays an essen-
tial role in the erythropoietin-dependent proliferation of CTLL-2 cells.
J Biol Chem
275:
35857-35862
107 Carroll MP, Spivak JL, McMahon M, Weich N, Rapp UR, May WS (1991) Erythropoietin
induces Raf-1 activation and Raf-1 is required for erythropoietin-mediated proliferation.
J Biol
Chem
266: 14964-14969
108 Sui X, Krantz SB, You M, Zhao Z (1998) Synergistic activation of MAP kinase (ERK1/2) by ery-
thropoietin and stem cell factor is essential for expanded erythropoiesis.
Blood
92: 1142-1149
109 Jacobs-Helber SM, Ryan JJ, Sawyer ST (2000) JNK and p38 are activated by erythropoietin
(EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57
cells.
Blood
96: 933-940
110 Shan R, Price JO, Gaarde WA, Monia BP, Krantz SB, Zhao ZJ (1999) Distinct roles of JNKs/p38
MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addi-
tion of erythropoietin.
Blood
94: 4067-4076
111 Umanoff H, Edelmann W, Pellicer A, Kucherlapati R (1995) The murine N-ras gene is not essen-
tial for growth and development.
Proc Natl Acad Sci USA
92: 1709-1713
112 Johnson L, Greenbaum D, Cichowski K, Mercer K, Murphy E, Schmitt E, Bronson RT, Umanoff
H, Edelmann W, Kucherlapati R et al. (1997) K-ras is an essential gene in the mouse with partial
functional overlap with N-ras.
Genes Dev
11: 2468-2481
113 Esteban LM, Fernandez-Medarde A, Lopez E, Yienger K, Guerrero C, Ward JM, Tessarollo L,
Santos E (2000) Ras-guanine nucleotide exchange factor Sos2 is dispensable for mouse growth
and development.
Mol Cell Biol
20: 6410-6413
114 Esteban LM, Vicario-Abejon C, Fernandez-Salguero P, Fernandez-Medarde A, Swaminathan N,
Yienger K, Lopez E, Malumbres M, McKay R, Ward JM et al. (2001) Targeted genomic disrup-
tion of H-ras and N-ras, individually or in combination, reveals the dispensability of both loci for
mouse growth and development.
Mol Cell Biol
21: 1444-1452
115 Bos JL (1989) Ras oncogenes in human cancer: A review.
Cancer Res
49: 4682-4689
116 Darley RL, Hoy TG, Baines P, Padua RA, Burnett AK (1997) Mutant N-RAS induces erythroid
lineage dysplasia in human CD34+ cells.
J Exp Med
185:1337-1347
117 Verdier F, Rabionet R, Gouilleux F, Beisenherz-Huss C, Varlet P, Muller O, Mayeux P, Lacombe
C, Gisselbrecht S, Chretien S (1998) A sequence of the CIS gene promoter interacts preferentially
with two associated STAT5A dimers: A distinct biochemical difference between STAT5A and
STAT 5B.
Mol Cell Biol
18: 5852-5860
118 Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A,
Yoshimura A (1997) CIS, a cytokine inducible SH2 protein, is a target of the JAK-STAT5 path-
way and modulates STAT5 activation.
Blood
89: 3148-3154
119 Moriggl R, Gouilleux-Gruart V, Jahne R, Berchtold S, Gartmann C, Liu X, Hennighausen L,
